(Q35901353)

English

Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Neisseria meningitidis

1 reference

based on heuristic

4

object named as

Jaime J Caro

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

author name string

Denis Getsios

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Ingrid Caro

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Wissam El-Hadi

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

International Journal of Technology Assessment in Health Care

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

280-288

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Risk factors for meningococcal disease in college students

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

How to vaccinate 30,000 people in three days: realities of outbreak management

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

A model for a smallpox-vaccination policy

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Impact of meningococcal C conjugate vaccine in the UK.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Mass Vaccination Campaign Following Community Outbreak of Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Meningococcal vaccine use in college students

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

The willingness to pay for health changes, the human-capital approach and the external costs.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Risk of meningococcal infection in college students.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Meningococcal disease in college students

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Herd immunity: history, theory, practice

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Should programmes for community-level meningococcal vaccination be considered in Australia? An economic evaluation.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

A proposed approach for modelling health-care systems for understanding.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Meningococcal disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

21 January 2018

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Should college students be vaccinated against meningococcal disease? A cost-benefit analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

How to calculate indirect costs in economic evaluations

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

A practical guide for calculating indirect costs of disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for meningococcal disease in university halls of residence

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Should we be doing more to prevent Group C meningococcal infection in school age children? How can we decide?

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal vaccination for adolescents? An economic evaluation in Victoria

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

The meningococcal vaccine recommendation: what a tangled web we weave

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001096

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0266462304001096

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35901353&oldid=1604895724"